A Retrospective Analysis of Full-face Dermal Filler Treatments: Product Choice, Volume Use, and Treatment Locations

Abstract

OBJECTIVE: The Vycross™ range of hyaluronic acid (HA) fillers supports a full-face approach to facial rejuvenation. It is important to understand how much filler can be safely injected and which products to use where, particularly for injectors who are new to this range. This study assessed whether Vycross fillers can be effectively and safely used in larger quantities and tracked real-world usage across facial zones. METHODS: This was a single-center, retrospective analysis set in normal clinical practice. The study included 66 consecutive adult female patients undergoing full-face rejuvenation with Vycross fillers within a single treatment plan guided by MD Codes. Filler usage and location were noted, and any adverse events were recorded. RESULTS: The mean age was 48.0 years, and median time from consultation to first filler usage was 18 days. Most patients (n=40; 60.6%) had only one filler session. Forty-seven patients (71.2%) also received botulinum toxin type A. In total, 309 filler syringes were used (mean: 4.7 per patient). Sixteen (5.2%), 181 (58.6%), and 112 (36.2%) syringes were used in the upper, mid and lower face, respectively. In the upper and midface, the majority was Voluma (15/16 and 120/181 syringes, respectively). In the lower face, filler use was split across Voluma, Volift and Volbella (41, 44 and 27 syringes, respectively). Five adverse events were reported at three weeks (swelling, n=2; asymmetry, n=2; lumps, n=1). All were easily resolved. No delayed events were reported. CONCLUSION: Substantial volumes of Vycross fillers can be effectively and safely used as part of a full-face approach to facial rejuvenation.

Keywords: Vycross; dermal filler; facial rejuvenation; hyaluronic acid.

FIGURE 1.

Full-face approach in a 55-year-old woman. The patient presented (A, B) complaining that her jawline looked too heavy and that she wanted to appear less masculine and have better cheek volume. She was treated with the Vycross range of products across two sessions to achieve facial slimming without the use of botulinum toxin. The patient received eight syringes of filler: six of Voluma (3 in the midface; 3 in the lower face), one of Volift (lower face), and one of Volbella (lips). Results at three weeks after the second session are shown in C and D.

FIGURE 2.

Full-face approach in a 64-year-old woman. The patient presented (A) wanting her face to look less saggy and more youthful. She was treated across two sessions to achieve chin advancement and jawline definition in the lower face and improve submental fullness. The patient received six syringes of Voluma: three in the midface and three in the chin. Results immediately following the second session are shown in B. This patient demonstrates the importance of treating the midface to help impact on the lower face.

FIGURE 3.

Full-face approach in a 64-year-old woman. The patient presented (A) wanting her face to look less tired and saggy. She was treated in one session with three syringes of Voluma: two in the midface and one in the lower face. Results at three weeks after the second session are shown in B. Improvements were achieved in the medial midface by revolumizing the deep medial cheek fat and medial sub-orbicularis oculi fat pad to help improve infraorbital hollowing, as well as recontouring of the chin and jawline.

FIGURE 4.

Full-face approach in a 41-year-old woman. The patient presented (A) wanting to look less tired. She was treated with the Vycross range of products in one session. The patient received four syringes of filler: two of Voluma (1 in temples; 1 in the midface), one of Volift (midface), and one of Volbella (tear troughs). Results at four weeks after the second session are shown in B. No filler was used in the lower face, but the restoration of volume in the midface had a substantial impact on the lower face.

FIGURE 5.

Full-face approach in a 56-year-old woman. The patient presented (A) wanting to look less saggy. She was treated in two sessions with four syinges of filler: two of Voluma, one of Volift, and one of Volbella. Results at three weeks after treatment are shown in B. By elongating the chin and volumizing the lips, facial narrowing was achieved.

FIGURE 6.

Distribution of dermal filler use across the lower, mid, and upper face.